Revision history of "Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer therapy" (Q37660489)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

31 May 2024

3 September 2022

1 May 2021

5 July 2020

31 January 2019

12 November 2018

17 March 2018

22 August 2017

21 August 2017